Acta Scientific Microbiology (ASMI) (ISSN: 2581-3226)

Short Communication Volume 3 Issue 5

Genome Editing in Gene and Cell-Based Therapies

Saranya Ganapathy and Sanjeev K Gupta*

Advanced Biotech Lab, Ipca Laboratories Ltd., Kandivli, Mumbai, India

*Corresponding Author: Sanjeev K Gupta, Advanced Biotech Lab, Ipca Laboratories Ltd., Kandivli, Mumbai, India.

Received: March 11, 2020; Published: April 14, 2020

×

Abstract

  Site-specific genetic modification has become a realistic possibility after nearly 50 years of research in the field of gene editing/ therapy. With the need for introducing exogenous fragment DNA or removing/modifying endogenous gene in/from a specific site in the genome of interest, precise genetic tools are being carefully designed for implementation. Creating Double Stranded Breaks (DSBs) at targeted sites in the genome of interest followed by endogenous cell based repair (Homology Directed Repair (HDR) or Non-Homologous End Joining (NHEJ)) results in genomic modifications [1]. With this approach, it is possible to carry out gene insertion, augmentation, deletion, gene sequence modification and mutation correction, aiding in the development of better animal disease models, ex vivo and in vivo gene repair and engineered cell based therapies.

Keywords: Double Stranded Breaks (DSBs); Homology Directed Repair (HDR); Non-Homologous End Joining (NHEJ)

×

References

  1. Takata M., et al. “Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells”. EMBO J 17 (1998): 5497-5508.
  2. Lundstrom K. “Viral Vectors in Gene Therapy”. Diseases2 (2018): 42.
  3. Renaud JB., et al. “Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases”. Cell Reports 14 (2016): 2263-2272.
  4. Chen F., et al. “High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases”. Nature Methods 8 (2011): 753-755.
  5. Gaj T., et al. “Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery”. Nucleic Acids Research11 (2017): 98.
  6. Devices CX., et al. “Engineered Viruses as Genome Editing Devices”. Molecular Therapy 3 (2016): 447-457.
  7. Gilbert LA., et al. “CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes”. Cell 154 (2013): 442-451.
  8. Qi LS., et al. “Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression”. Cell 152 (2013): 1173-1183.
  9. Wang M., et al. “Non-viral delivery of genome-editing nucleases for gene therapy”. Gene Therapy 24 (2017): 144-150.
  10. Yin H., et al. “Delivery technologies for genome editing”. Nature Reviews Drug Discovery 16 (2017): 387-399.
  11. Miller JC., et al. “Enhancing gene editing specificity by attenuating DNA cleavage kinetics”. Nature Biotechnology 37 (2019): 945-952.
  12. Liu RM., et al. “Synthetic chimeric nucleases function for efficient genome editing”. Nature Communications 10 (2019): 5524.
  13. Li J., et al. “Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing”. Journal of Genetics and Genomics11 (2019): 513-521.
  14. Puig-Saus C., et al. “Gene editing: Towards the third generation of adoptive T-cell transfer therapies”. Immuno-Oncology Technology 1 (2019): 19-26.
  15. Golchin A., et al. “Biological Products: Cellular Therapy and FDA Approved Products”. Stem Cell Rev Stem Cell Reviews and Reports 15 (2019): 166-175.
  16. Anguela XM., et al. “Entering the Modern Era of Gene Therapy”. High Annual Review of Medicine1 (2019): 273-288.
×

Citation

Citation: Saranya Ganapathy and Sanjeev K Gupta. “Genome Editing in Gene and Cell-Based Therapies". Acta Scientific Microbiology 3.5 (2020): 23-25.



Member In






News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 15, 2020.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US